Access Bio, Inc.

Medical device company · Somerset, New Jersey, United States

Access Bio, Inc. is a medical device company headquartered in Somerset, New Jersey, United States. The US FDA lists 1 medical device site registered to the company, with devices in microbiology, clinical chemistry and hematology. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Access Bio at a glance

Typemedical device company
HeadquartersSomerset, New Jersey, United States
FDA-registered sites1
SEC CIK1195790

What does Access Bio do?

Medical specialties of its FDA-listed devices

MicrobiologyClinical ChemistryHematology

Device types listed with the FDA

Coronavirus antigen detection test system.Multi-analyte controls, all kinds (assayed)Multi-analyte respiratory virus antigen detection testReagents, 2019-novel coronavirus nucleic acidReagent, coronavirus serologicalOver-the-counter covid-19 antigen testReagents, non-variola orthopoxvirus or monkeypox virus singleplex antigen testsPlasmodium spp. detection reagents

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $10 million sold (2020).

Where is Access Bio located?

Headquarters: Somerset, New Jersey, United States

  • Monroe Township, New JerseyAccess Bio, Inc. · FDA device site

Frequently asked questions about Access Bio

Where is Access Bio headquartered?

Access Bio, Inc. is headquartered in Somerset, New Jersey, United States.

What does Access Bio do?

Access Bio, Inc. is a medical device company. Its FDA-listed medical devices fall under microbiology, clinical chemistry and hematology.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences